EODData

MEMBERSHIP REGISTER LOG IN

ASX, ATX: Amplia Therapeutics Ltd.

17 Nov 2025
LAST:

0.1150

CHANGE:
 0.02		OPEN:
0.1250		HIGH:
0.1250		ASK:
0.1900		VOLUME:
967.0K
CHG(%):
11.54		PREV:
0.1300		LOW:
0.1150		BID:
0.1850		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Nov 250.12500.12500.11500.1150967.0K
14 Nov 250.12500.13000.12500.130089.1K
13 Nov 250.12750.13000.12750.1300340.6K
12 Nov 250.12500.13000.12500.1300294.6K
11 Nov 250.13000.13000.12500.1300131.5K
10 Nov 250.13000.13000.12500.130082.9K
07 Nov 250.12000.13000.12000.1300220.4K
06 Nov 250.12000.12500.12000.120042.8K
05 Nov 250.13000.13250.11500.12002.88M
04 Nov 250.13500.14000.13000.1350294.7K

PROFILE

Name:Amplia Therapeutics Ltd.
About:Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreatic cancer; and treatment of idiopathic pulmonary fibrosis, as well as ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:90 William Street, Melbourne, VIC, Australia, 3000
Website:https://www.ampliatx.com
ISIN:AU0000023822
FIGI:BBG005M56X12

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.31 
Forward P/E:-6.43 
Price to Sales:18.98 
Price to Book:2.50 
Profit Margin:-1.74 
Operating Margin:-1.66 
Return on Assets:-0.22 
Return on Equity:-0.41 
EPS Ratio:-0.02 
Revenue:3.78M 
Shares:513.07M 
Market Cap:59.0M 

TECHNICAL INDICATORS

MA5:0.1310.4%
MA10:0.1310.4%
MA20:0.1313.1%
MA50:0.1528.3%
MA100:0.1964.4%
MA200:0.1315.2%
RSI14:41.67
WPR14:-100.00 
MTM14:-0.01
ROC14:-0.08 
ATR:0.01 
Week High:0.1313.0%
Week Low:0.120.0%
Month High:0.1530.4%
Month Low:0.1215.2%
Year High:0.43269.6%
Year Low:0.05134.7%
Volatility:46.75 

RECENT SPLITS

Date Ratio
30 Apr 20181-10